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Renal hemodynamies during separate and combined Infusion of amino
acids and dopamine. Healthy volunteers (N = 9) and patients with
varying degrees of renal insufficiency (N = 36) were given a low dose of
dopamine and/or amino acids intravenously during a simultaneous
measurement of the glomerular filtration rate and the effective renal
plasma flow. Dopamine infusion led to a rise in the glomerular filtration
rate and a fall in the filtration fraction. Infusion of amino acids was
accompanied by an increase in the glomerular filtration rate while the
filtration fraction remained unchanged or increased slightly. The highest
values for the glomerular ifitration were obtained during the combined
infusion of amino acids and dopamine. A reserve in filtration capacity
was not or hardly present in patients with moderate (GFR 30 to 90
mliter/min/l .73 M2) to severe (GFR < 30 mliter/minll,73 M2) renal
insufficiency. We conclude that dopamine decreases total renal vascular
resistance while amino acids mainly reduce the tone of afferent arteri-
oles. As amino acids and dopamine seem to be additive in their effects
on the glomerular filtration rate, we recommend the combined infusion
of these two stimuli to measure renal reserve filtration capacity.
Both a diet rich in protein [1—3] and an intravenous infusion of
amino acids [4—6] cause an increase in glomerular filtration rate
(GFR), provided that renal function is not severely impaired [7,
8]. A meat meal has been recommended to measure the
so-called "renal functional reserve" [8], that is, the absence of
glomerular hyperfiltration.
Recently, we found in patients with IgA glomerulopathy that
a low dose of dopamine increased GFR if the baseline GFR
amounted to 73 mliter/min/l .73 M2 or more [9]. The relative
changes in GFR increased with increasing baseline values (r =
0.74, p < 0.001). Thus, a low dose of dopamine administered
during simultaneous measurement of GFR and effective renal
plasma flow (ERPF) could be an alternative for a meat meal or
an amino acid infusion if the presence (or absence) of
hyperfiltration has to be determined. However, in a study on
the effect of an amino acid solution on GER and ERPF, we
observed that amino acids, in contrast with dopamine, barely
affected the filtration fraction, that is, the renal vascular resist-
ance [10].
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The aim of this study, therefore, was to compare the effects
of amino acids and a low dose of dopamine, separately or
simultaneously infused, on the GFR and ERPE in healthy
volunteers, in healthy individuals after nephrectomy, and in
patients with a renal disease with or without impaired function.
Methods
Five groups were studied consisting of nine healthy volun-
teers (group I), nine healthy kidney donors (group III), nine
renal patients with a GFR 90 mliter/minll .73 M2 (group III),
11 patients with moderate renal insufficiency, i.e., a GFR
between 30 to 90 mliter/min/1 .73 M2 (group IV), and seven
patients with severely impaired renal function, i.e., a GFR C 30
mliter/min/l .73 M (group V). Renal diseases included essential
hypertension (N = 6), focal glomerulosclerosis (N = 6), IgA
glomerulopathy (N = 4), membranous glomerulopathy (N = 3),
interstitial nephritis (N = 3), polycystic kidney disease (N = 1),
and miscellaneous (N = 4).
The medical ethics committee approved the study protocol
and all the individuals verbally consented to an infusion of
amino acids and/or dopamine.
The measurements were performed on two separate days.
With the standard procedure baseline GFR and ERPF were
measured simultaneously on day one, using '251-iothalamate
and '311-hippurate according to a method previously described,
with coefficients of variation of the day to day determinations of
2.2 and 5.0%, respectively [11]. After a priming dose was given,
the radiopharmaceuticals were infused at a constant rate (Braun
Unita II pump). After an equilibration period of 1.5 hr, two 2—hr
clearances were determined, each calculated from the 2-hr
urinary tracers excretion and the mean serum tracer value from
three samples drawn at the start, midway and at the end of each
2—hr period. During the procedure a diuresis of at least 100
mliter/hr was maintained by orally administering fluids. At the
end of this standard procedure, dopamine was infused at a rate
of 1.5 to 2.0 gIkgImin for two hr. GFR and ERPF during these
two hr were compared with the GFR and ERPE just before the
infusion of this agent.
At 18.00 hrs on day two, the infusion of VaminRN (a 7%
amino acid solution) was started at a rate of 500 mliter/hr (=83
mliter/hr), analogous to the study of von Graf et al who infused
a 10% amino acid solution at a rate of 60 mliter/hr [6]. On day
three, GFR and ERPF were measured a second time as outlined
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Table 1. The effects of dopamine infusion (D), amino acid infusion (A), and combined infusion (A + D) on the GFR (mliters/minll .73 M2) and
FF in healthy subjects.
Group
GFR FF
BL D A A+DBL D A A+D
I Median 115 125* 126* 143*,** 0.23 0.19* 0.24 021*,**
Mean 115 129 127 140 0.24 0.20 0.24 0.21
SEM(±) 7 8 7 8
II Median 72 76 76* 80*,** 0.25 0.23* 0.26 022*,**
Mean 67 72 74 79 0.25 0.22 0.26 0.22
SEM(±) 5 7 5 6
Symbols are: * significant vs. baseline (BL); ** significant vs. D.
Table 2. The effects of dopamine infusion (D), amino acid infusion (A), and combined infusion (A + D) on the GFR (mlIminIl .73 M2) and FF
in patients with renal disease.
Group
GFR FF
BL D A A + DBL D A A + D
III Median 117 116 120 131 .25 .22* .26 .23*.**
Mean 115 124 125 132 .25 .21 .25 .21
SEM(±) 1 6 4 7
IV Median 59 66* 69 77 .23 .21* .22 .21
Mean 61 64 64 72 .22 .20 .23 .21
SEM(±) 6 6 6 6
V Median 11 10 11 11 .19 .19 .20 .21*
Mean 13 13 14 12 .19 .19 .21 .22
SEM(±) 2 2 2 3
Symbols are: * significant vs. baseline (BL); ** significant vs. D.
above while the amino acid infusion was continued, including
the infusion of low—dose dopamine at the end of the procedure.
Filtration fraction (FF) was defined as the ratio GFR:ERPF.
The normal value of the FF in our laboratory varies between
0.22 and 0.28.
Before and during the administration of dopamine, heart rate
(HR) and blood pressure were recorded at 15 mm intervals for
four hours. Mean arterial pressure (MAP) was calculated by
adding one third of the pulse pressure to the diastolic pressure.
Paired and unpaired Wilcoxon rank sum tests were used for
the statistical analysis of the data. This was performed on
median values as we considered our data (especially dopamine—
and amino acid—induced changes in GFR and ERPF) not
normally distributed. To study correlations, linear regression
analysis [12] or Spearman's rank correlation test were used. A
probability value of 5%was chosen as the level of significance.
Results
Neither the dopamine infusion, nor the amino acid infusion
nor the combined infusion caused significant changes in HR or
MAP. In the combined groups Ito V, median HR values were
72 beats per mm (bpm) baseline, 76 bpm during dopamine
infusion, 78 bpm during amino acid infusion and 76 bpm during
the combined infusion. Median MAP values were 97 mmHg
baseline, 97 mmHg during dopamine infusion, 102 mmHg
during amino acid infusion and 103 mmHg during combined
infusion.
In the healthy volunteers (group I) both the dopamine infu-
sion and the amino acid infusion caused significant increases in
GFR (P < 0.05) which were of comparable magnitude (Table I).
The largest rise in GFR, however, was observed during the
combined infusion. Inhealthy individuals after uninephrectomy
(group II), the increase in GFR did not reach significance during
the dopamine infusion but did during the amino acid infusion (P
<0.05). Here as well, combined infusion increased GFR most
(Table I).
In Table II, the effects of the dopamine, amino acids and
combined infusion on GFR in patients with renal diseases are
listed. In group III no significant changes in GFR could be
obtained. In group IV only the dopamine infusion increased
GFR significantly. In patients with severely impaired renal
function (group V) neither the dopamine infusion, nor the amino
acid infusion nor the combined infusion changed GFR.
As can be seen in Table I and II, the dopamine infusion
caused a fall in the FF in all the groups except group V. Infusion
of amino acids, however, either did not change the FF or
slightly increased it. This indicates that dopamine and amino
acids affect renal hemodynamics in different ways. Figure 1
shows the effects of the dopamine infusion, the amino acid
infusion and the combined infusion on the ERPF. This figure
also shows that the dopamine infusion increased ERPF,
whereas the amino acid infusion barely affected ERPF. Further-
more, in severe renal insufficiency no changes in ERPF could
be observed.
Spearman's rank test revealed a positive relation between the
baseline ERPF and the change in ERPF during dopamine
infusion. During the amino acid infusion no such relationship
could be found (Fig. 2). Figure 3 shows that similar findings
were obtained for the baseline GFR and the absolute changes in
GFR, that is, a positive relation during dopamine infusion and
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no significant relation during amino acid infusion (P <0.1). The
absolute change in GFR appeared to be strongly related to the
absolute change in ERPF during the dopamine infusion as well
as the amino acid infusion and the combined infusion (Fig. 4).
Using linear regression analysis we found during the dopamine
infusion that the LGFR —1,8164 + 0.0989 (ERPF mi/mm (r
= 0.87; P < 0.001) during the amino acid infusion sGFR =
3.6444 + 0.1737 LIIERPF muter/mm (r = 0.73; P < 0.001), and
during the combined infusion ZGFR = —1.2910 + 0.1270
ERPF muter/mm (r = 0.81; P < 0.001). The relation between
AGFR and LLERPF during the dopamine infusion proved to be
different from the relation between zGFR and ERPF during
the amino acid infusion.
In the combined groups Ito V, administration of amino acids
appeared to increase urine volume (P < 0.05) compared with
both urine volume during the baseline measurement and urine
volume during the dopamine infusion. Median urine volumes
(mliter/2 hr) were 340 (baseline), 302 (dopamine infusion), 390
Fig. 1. The effects of dopamine (2), amino acids (3) and the
combined infusion (4) on the ERPF of the 45 subjects, plotted
individually (left panel) and on the median ERPF (right panel) of
the control group (—), the subjects with one kidney ( ),
and the patients with renal disease (—normalfunction; —
moderate renal failure; severe renal failure). I = baseline.
S. Fig. 2. The relation between the absolute change in ERPF
(ERPF) and baseline ERPF during infusion of dopamine
(r 0.79, P < 0.001, N = 45) and amino acids (r = 0,06,
NS,N45).
(amino acid infusion) and 431 (combined infusion). The addition
of dopamine to amino acids did not change urine volume
significantly.
Sodium excretion in groups I to V combined was only
increased (P < 0.05) during the combined infusion of amino
acids and dopamine compared with baseline sodium excretion.
Median sodium excretions (mmole/2 hr) were 20.7 (baseline),
26.6 (dopamine), 31.4 (amino acids) and 31.9 (combined
infusion).
Discussion
Renal plasma flow, net ultrafiltration pressure, colloid os-
motic pressure of plasma and the ultrafiltration coefficient are
the determinants of glomerular ultrafiltration [131. In both
filtration equilibrium and filtration disequilibrium, an increase in
renal blood flow, induced by a decreased renal vascular resist-
ance for instance, will result in an increase in glomerular
ultrafiltration [13, 14].
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Fig. 4. iGFR versus AERPF during infusion of dopamine (D), infusion
of amino acids (A) and during the combined infusion (A + D).
A general decrease in renal vascular resistance can be ob-
tained by infusing a low dose of dopamine. This agent causes
efferent and afferent vasodilatation by binding to specific
dopaminergic vascular receptors [15]. The decreased vascular
resistance results in an increased renal plasma flow, an in-
creased glomerular filtration rate and a fall in filtration fraction.
Indeed these effects of dopamine were observed in the present
study unless renal function was severely impaired. In renal
patients with a normal GFR, no significant rise in GFR could be
obtained, a phenomenon probably due to the small number of
patients and/or the variety of renal diseases. After eliminating
three patients with essential hypertension for instance, the GFR
values were parallel to the control group.
Glomerular filtration rate can also be increased by infusing
amino acids [5, 6, 10]. Although this may occur partially
because of a direct effect of amino acids on renal hemodynam-
ics [16, 17], the effect of an amino acid—induced release of the
postulated liver hormone glomerulopressin seems more impor-
tant [18, 19]. Recently, it has been demonstrated that no rise in
GFR can be obtained after a meat meal in patients with severe
liver disease [20]. Glomerulopressin causes afferent vasodilata-
tion [21] and therefore increase GFR by a rise in net ultrafiltra-
tion pressure without affecting or only slightly elevating FF.
Our observations that amino acids can increase GFR without
affecting FF are in accord with the above mentioned hypothe-
sis. Again, in severe renal disease no rise in GFR could be
obtained during amino acid infusion.
As dopamine and amino acids influence GFR in different
ways, it is understandable why the highest values of GFR were
observed during the combined infusion; an amino acid—induced
increase of the ultrafiltration pressure and a dopamine—induced
increase in renal plasma flow are additive. It may be that
infusing amino acids in larger amounts than used in this study
combined with a low dose of dopamine will result in even higher
values of GFR than those observed in the present study and
measures best the so—called renal reserve filtration capacity.
Changes in GFR induced by infusion of amino acids are not
likely caused by the hyperosmolality of the amino acid solution.
In a recent study we demonstrated that infusion of manntol 20%
did not change GFR or ERPF [10].
Interestingly, the relative effect of dopamine on baseline
ERPF and baseline GFR was greater in the normal volunteers
when compared to the subjects after uninephrectomy (median
increase in ERPF 34 vs. 21%, P < 0.05 and median increase in
GFR 11 vs. 6%, respectively); however, the relative effect of
amino acids on baseline GFR was the same in both groups (9 vs.
10%, respectively). The combined infusion increased ERPF 23
vs. 24%, and GFR 13 vs. 22% (NS). It may be that we only
found a difference between the two groups with dopamine
because of the small number of individuals studied. Perhaps
such a difference could be found if the subjects in group II were
studied during amino acid infusion and the combined infusion in
a paired way before and after nephrectomy. Another explana-
tion may be that after uninephrectomy total renal vascular
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resistance is decreased without substantially affecting afferent
tone.
In conclusion, amino acids and dopamine increase filtration
by different mechanisms as expressed by the filtration fraction.
The combination leads to the highest values for the GFR
without an influence on systemic blood pressure or heart rate.
The results support the hypothesis that if in renal disease GFR
is severely impaired, a significant reserve in renal function is no
longer present.
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Appendix
VaminRN (Kabi Vitrum, Limoges, France) contains per 1000
mliter: 1-asparaginic acid 4.1 g; l-glutaminie acid 9.0 g; 1-alanin
3.0 g; 1-arginine 3.3 g; 1-cysteine/cystine 1,4 g; glyeine 2.1 g;
1-histidine 2.4 g; 1-isoleucine 3.9 g; 1-leucine 5.3 g; 1-lysine 3.9
g; 1-methionine 1.9; 1-phenylalanine 5.5 g; 1-proline 8.1 g;
1-serine 7.5 g; 1-threonine 3.0 g; 1-tryptophan 1.0 g; 1-tyrosine
0.5 g and 1-valine 4.3 g.
Reprint requests to P. M. ter Wee, University Hospital Groningen, 59
Oostersingel, 9713 EZ Groningen, The Netherlands
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